Literature DB >> 19878222

Comparison of the AcrySof SA60 spherical intraocular lens and the AcrySof Toric SN60T3 intraocular lens outcomes in patients with low amounts of corneal astigmatism.

Michael Statham1, Andrew Apel, David Stephensen.   

Abstract

BACKGROUND: Toric intraocular lenses (IOLs) have been reported to be an effective method of reducing postoperative refractive astigmatism and spectacle dependence following cataract surgery. This study compares a series of patients with low corneal astigmatism implanted with either the AcrySof SA60 spherical IOL or the AcrySof Toric SN60T3 IOL in a quantitative fashion to establish the merit of toric IOLs in these cases.
METHODS: A retrospective chart audit was undertaken of 12 patients receiving the AcrySof Toric SN60T3 IOL (1.5 DC, Alcon, Fort Worth) and 10 patients receiving the AcrySof SA60 IOL (Alcon, Fort Worth). Preoperative corneal astigmatism and postoperative refractive astigmatism were recorded and converted into a non-signed Astigmatic Power Vector for statistical analysis. Postoperative vision (uncorrected visual acuity, UCVA) was also recorded for both groups. A statistical analysis was performed to examine for differences in outcomes between groups.
RESULTS: The mean magnitude of the preoperative corneal Astigmatic Power Vector was not significantly different between the groups. The mean magnitude of the postoperative refractive vector was significantly smaller in the AcrySof Toric group. The mean UCVA was significantly better in the AcrySof Toric group compared with the AcrySof group.
CONCLUSION: The AcrySof Toric IOL provides a significant improvement in postoperative astigmatism and UCVA when compared statistically with its spherical counterpart for patients with low degrees of corneal astigmatism.

Entities:  

Mesh:

Year:  2009        PMID: 19878222     DOI: 10.1111/j.1442-9071.2009.02154.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  9 in total

1.  The refractive outcome of Toric Lentis Mplus implant in cataract surgery.

Authors:  Patrick J Chiam; Say A Quah
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

2.  Which keratometer is most reliable for correcting astigmatism with toric intraocular lenses?

Authors:  Minwook Chang; Su-Yeon Kang; Hyo Myung Kim
Journal:  Korean J Ophthalmol       Date:  2012-01-14

3.  Effects of posterior corneal astigmatism on the accuracy of AcrySof toric intraocular lens astigmatism correction.

Authors:  Bin Zhang; Jing-Xue Ma; Dan-Yan Liu; Cong-Rong Guo; Ying-Hua Du; Xiu-Jin Guo; Yue-Xian Cui
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

4.  Visual performance in cataract patients with low levels of postoperative astigmatism: full correction versus spherical equivalent correction.

Authors:  Robert P Lehmann; Diane M Houtman
Journal:  Clin Ophthalmol       Date:  2012-03-02

5.  Cataract Surgery in Eyes with Low Corneal Astigmatism: Implantation of the Acrysof IQ Toric SN6AT2 Intraocular Lens.

Authors:  Jaskirat S Aujla; Stephen J Vincent; Shane White; Jai Panchapakesan
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

6.  Bilateral implantation of +3.0 D multifocal toric intraocular lenses: results of a US Food and Drug Administration clinical trial.

Authors:  Robert Lehmann; Satish Modi; Bret Fisher; Magda Michna; Michael Snyder
Journal:  Clin Ophthalmol       Date:  2017-07-20

Review 7.  Optimizing outcomes with toric intraocular lenses.

Authors:  Manpreet Kaur; Farin Shaikh; Ruchita Falera; Jeewan S Titiyal
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

Review 8.  Toric intraocular lenses: Evidence-based use.

Authors:  Michael Goggin
Journal:  Clin Exp Ophthalmol       Date:  2022-05-29       Impact factor: 4.383

9.  Maximising Refractive Outcomes with an Extended Depth of Focus IOL.

Authors:  Barry Power; Rory Murphy; Antonio Leccisotti; Tara Moore; William Power; Paul O'Brien
Journal:  Open Ophthalmol J       Date:  2018-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.